Results 101 to 110 of about 15,859 (208)

Stereotactic ablative radiotherapy (SABR) for liver metastases: where we currently stand

open access: yesESMO Gastrointestinal Oncology
Stereotactic ablative radiotherapy (SABR), which is already used as the standard-of-care treatment in other cancers such as lung, is being increasingly used in the treatment of liver metastases in the oligometastatic setting in unresectable, pre-treated ...
S.H.R. Kim, M.K. Harrison
doaj   +1 more source

Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases

open access: yesFrontiers in Oncology, 2019
Purpose: This study aimed to describe our institutional experience in the use of stereotactic body radiation therapy (SBRT) for the management of adrenal gland metastases from multiple primary cancers.Materials and Methods: We retrospectively reviewed 31
Cyrielle Scouarnec   +7 more
doaj   +1 more source

Oligometastatic NSCLC: Current Perspectives and Future Challenges

open access: yesCurrent Oncology
Oligometastatic non-small cell lung cancer (NSCLC) represents a separate entity with a different biology and prognosis compared to stage IV NSCLC. Challenges range from the very definition of oligometastatic disease to the timing and techniques of local treatments, and their benefit in prolonging patient survival.
Sara Torresan   +5 more
openaire   +5 more sources

Management of oligometastatic triple-negative breast cancer with lung metastasis using 4DCT: a case report

open access: yesJournal of Current Oncology and Medical Sciences
Introduction: Breast cancer remains the most prevalent disease in women. Oligometastatic breast cancer (OMBC), is defined by a limited disease burden. 40% of Triple negative breast cancer are associated with Lung metastasis.
Siddharth Arora, Kriti Grover
doaj  

MRI-Guided Adaptive Radiation Therapy for Oligometastatic Prostate Cancer Involving the Adrenal Gland: A Case Report and Literature Review

open access: yesCase Reports in Oncology
Introduction: Metastasis-directed therapy is an evolving treatment modality for patients with oligometastatic prostate cancer. Although the microenvironment of the adrenal glands is enriched in androgen precursors, isolated adrenal metastases ...
Fabian J. Bolte   +3 more
doaj   +1 more source

Lung oligometastatic disease

open access: yes, 2022
Cancer is one of the leading causes of death worldwide. In more than 90% of cases, patients die as a consequence of development of metastases, the diffusion of cancer cells in distant organs from the primary tumor site. This process, which accounts for the high mortality of patients with this condition, is one of the less understood steps of cancer ...
openaire   +1 more source

Oligometastatic disease in esophagogastric cancer

open access: yes
Patients with limited metastatic esophageal or gastric cancer (oligometastatic esophagogastric cancer) may benefit from local treatment of oligometastases combined with systemic therapy. This PhD thesis investigates the development of a multidisciplinary
Kroese, Tiuri   +6 more
core  

Abstract 2234: Circulating tumor cells are rare in patients with curable oligometastatic cancer

open access: yes, 2010
Background: In the majority of patients with solid organ malignancies, tumor metastasis marks a transition from curable to terminal. However, a subset of metastatic cancer patients develops only a very limited number of metastases (known as ...
David L. Rimm   +5 more
core   +1 more source

Observation of preliminary clinical effect and analysis of perioperative complications of radical rostatectomy for patients with oligometastatic prostate cancer

open access: yesZhongguo aizheng zazhi, 2017
Background and purpose: It has been demonstrated that radical prostatectomy for patients with oligometastatic prostate cancer may contribute to improving local control of prostate cancer and overall survival by several retrospective studies ...
李高翔, 戴 波, 叶定伟
doaj  

Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach

open access: yesExploration of Targeted Anti-tumor Therapy
Recently, the development of targeted therapy approaches such as those based on tyrosine kinase inhibitor (TKI) greatly improved the clinical outcomes of patients affected by oncogene addicted advanced non-small cell lung cancer (NSCLC).
Francesca Di Pressa   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy